CAD 0.15
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.08 CAD | 81.47% |
2022 | -0.43 CAD | 14.0% |
2021 | -0.50 CAD | 0.0% |
2020 | - CAD | 100.0% |
2019 | -0.12 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q2 | -0.03 CAD | -33.68% |
2023 Q3 | -0.01 CAD | 65.35% |
2023 Q1 | -0.02 CAD | 93.21% |
2023 Q4 | -0.02 CAD | -182.95% |
2022 FY | - CAD | 14.0% |
2022 Q1 | -0.01 CAD | 42.47% |
2022 Q4 | -0.28 CAD | -889.4% |
2022 Q3 | -0.03 CAD | -26.91% |
2022 Q2 | -0.02 CAD | -165.48% |
2021 Q1 | -0.01 CAD | 50.65% |
2021 FY | - CAD | 0.0% |
2021 Q2 | -0.01 CAD | -82.89% |
2021 Q4 | -0.01 CAD | -8.15% |
2021 Q3 | -0.01 CAD | 2.88% |
2020 Q4 | -0.02 CAD | -55.56% |
2020 Q3 | -0.01 CAD | 2.94% |
2020 FY | - CAD | 0.0% |
2020 Q2 | -0.01 CAD | -142.86% |
2020 Q1 | -0.00 CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 82.289% |
Asep Medical Holdings Inc | -0.13 CAD | 38.692% |
BetterLife Pharma Inc. | -0.03 CAD | -201.894% |
BioVaxys Technology Corp. | -0.06 CAD | -39.092% |
ChitogenX Inc. | -0.02 CAD | -274.178% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | -94.39% |
Defence Therapeutics Inc. | -0.30 CAD | 73.433% |
Entheon Biomedical Corp. | -0.05 CAD | -56.89% |
Gemina Laboratories Ltd. | -0.07 CAD | -10.694% |
Glow Lifetech Corp. | -0.03 CAD | -176.736% |
Lexston Life Sciences Corp. | -0.02 CAD | -246.522% |
Pharmala Biotech Holdings Inc. | -0.01 CAD | -766.304% |
MYND Life Sciences Inc. | -0.03 CAD | -148.287% |
Nova Mentis Life Science Corp. | -0.01 CAD | -860.241% |
PharmaTher Holdings Ltd. | -0.04 CAD | -125.779% |
PreveCeutical Medical Inc. | -0.00 CAD | -3220.833% |
Telescope Innovations Corp. | -0.12 CAD | 33.583% |